GSK to accelerate drug discovery with artificial intelligence company

GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug.
It has entered into an alliance with Exscientia, a new UK company which has developed its own AI platform,...

More From BioPortfolio on "GSK to accelerate drug discovery with artificial intelligence company"

Relevant Topics

The Top 100 Pharmaceutical CompaniesTop 10 biotech and pharmaceutical companies worldwide based on market value in 2015
2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars)
Johnson & Johnson, U.S.
74...

Mergers & AcquisitionsCommercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...